Establishment ＆ Mission

　　　The Center for Drug Evaluation (CDE) was established by the Department of Health (DOH) of Taiwan on July 13, 1998 with the vision "Regulatory, for Life". CDE plays a pivotal role in enhancing the efficiency and quality of drug evaluation, thus promoting public health and welfare including timely access to innovative medicines. CDE evaluates new drugs and new medical devices for regulatory requirements and offers related consultation services under the delegation and commission of DOH. Furthermore, CDE develops pharmaceutical regulatory science and makes timely recommendations to meet the need of policy development.  Thus, CDE contributes to the national public health system and ensures that the public can obtain safe and effective innovative new drugs in a timely manner through the efforts of a team of full-time professionals .